Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Ernexa Therapeutics Inc. (ERNA) vs Evogene Ltd. (EVGN)

Ernexa Therapeutics Inc. and Evogene Ltd. are both Biotechnology companies. Ernexa Therapeutics Inc. and Evogene Ltd. are of similar size ($6.3M and $5.9M). Evogene Ltd. grew revenue faster over the last twelve months: −54.7% against −78.6%. Ernexa Therapeutics Inc. has the higher net margin (0.00% vs −547.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Evogene Ltd. leads on 10 and Ernexa Therapeutics Inc. on 6.

Valuation

Metric ERNA EVGN Biotechnology median
P/E n/m n/m 7.88
P/S 7.01 3.09 11.47
P/B 1.28 0.89 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.39 0.74
EV/Sales 55.39 (2.55) 10.73
Earnings yield (415.94%) (216.67%) (28.84%)
Free cash flow yield (217.53%) (210.40%) (23.03%)

Profitability

Metric ERNA EVGN Biotechnology median
Gross margin 83.51% (67.59%) 65.16%
Operating margin 0.00% (851.42%) 0.00%
Net margin 0.00% (547.62%) 0.00%
Free cash flow margin 0.00% (650.63%) 0.00%
Return on equity (321.22%) (100.03%) (57.72%)
Return on assets (176.62%) (38.31%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ERNA EVGN Biotechnology median
Revenue growth (TTM) (78.60%) (54.71%) 5.64%
EPS growth (last fiscal year) 95.42% 62.63% —
Revenue growth, 5-year CAGR (50.61%) 29.94% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERNA EVGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 3.57 4.73
Net debt to EBITDA 0.21 1.12 0.96

Dividend

Metric ERNA EVGN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ERNA EVGN Biotechnology median
Market cap 5.91m 6.32m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack